Stocks and Investing
Stocks and Investing
Mon, August 29, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Sun, August 28, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Fri, August 26, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Yigal Nochomovitz Maintained (ZYME) at Strong Buy with Decreased Target to $27 on, Aug 26th, 2022
Yigal Nochomovitz of Citigroup, Maintained "Zymeworks Inc." (ZYME) at Strong Buy with Decreased Target from $28 to $27 on, Aug 26th, 2022.
Yigal has made no other calls on ZYME in the last 4 months.
There are 3 other peers that have a rating on ZYME. Out of the 3 peers that are also analyzing ZYME, 0 agree with Yigal's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Yigal
- Andrew Berens of "SVB Leerink" Maintained at Buy with Increased Target to $19 on, Friday, May 27th, 2022
- Robert Burns of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $40 on, Monday, May 23rd, 2022
- Charles Zhu of "Guggenheim" Upgraded from Hold to Strong Buy and Held Target at $14 on, Thursday, May 5th, 2022
Contributing Sources